Kewaunee Scientific Corporation
Cash Flow Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $9.6M | $11.4M | $18.8M | $738.0K | $-6.1M | $-3.7M | $-4.7M | $1.5M |
| Depreciation & Amortization | $6.3M | $4.8M | $3.1M | — | — | — | — | — |
| Depreciation | $4.7M | $4.0M | $3.1M | $2.9M | $2.8M | $2.7M | $2.7M | $2.6M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.1M | $1.4M | $1.0M | $886.0K | $729.0K | $634.0K | $251.0K | $197.0K |
| Net Cash from Operating Activities | $18.6M | $14.8M | $19.6M | $-3.8M | $-7.9M | $912.0K | $4.2M | $2.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.9M | $2.2M | $4.4M | $4.1M | $1.9M | $2.4M | $2.5M | $4.2M |
| Business Acquisitions | $0 | $28.7M | $0 | — | — | — | — | — |
| Net Cash from Investing Activities | $-3.9M | $-30.9M | $-4.4M | $-4.1M | $-1.9M | $-2.4M | $-2.5M | $-4.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | $0 | $1.0M | $2.0M |
| Stock Repurchases | $0 | $1.6M | $2.0M | $0 | — | — | — | — |
| Net Cash from Financing Activities | $-19.3M | $7.4M | $-3.0M | $14.9M | $11.0M | $2.0M | $-7.5M | $2.3M |
| Net Change in Cash | $-5.5M | $-8.8M | $12.1M | $6.9M | $1.2M | $516.0K | $-5.9M | $198.0K |
| Free Cash Flow | $14.7M | $12.6M | $15.2M | $-7.9M | $-9.8M | $-1.5M | $1.7M | $-1.7M |